ANVS

Annovis Bio Inc

1.330

+0.060+4.72%

Pre Market: 1.340 +0.010 +0.75%06:22 09/25 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.270/1.270

TODAY RANGE1.230-1.340

VOL51

MARKET CAP56.76M

52 WEEK RANGE1.040-5.50

AVG VOL (3M)932.69K

% TURNOVER1.98%

TURNOVER0

P/E (TTM)-0.7469

% RANGE8.66%

EPS(TTM)-1.7806

P/E(FORWARD)-0.9433

P/B-13.3133

BVPS-0.0999

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP50.07M

SHARES OUTSTANDING42.68M

NEXT EARNINGS11/10-11/16

FREE FLOAT37.65M

LOT SIZE1

EX-DATE--

Feeds

News

Press Releases

Financial Reports

Profile

Same Industry

Name/Symbol

Change%

Price

ANVS

Regeneron Pharmaceuticals

REGN

-0.58%

784.85

GRDX

BNTX

United Therapeutics Corp.

UTHR

-0.53%

494.63

Vertex Pharmaceuticals Inc

VRTX

+0.84%

514.99

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

-2.55%

154.04

Charles Riv Labs Intl Inc

CRL

-1.28%

278.06

MEDP

TLPH

ICON plc

ICLR

-1.92%

163.90

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+1.30%

269.88

MOLECULAR PARTNERS AG

MOLN

+7.40%

4.210

Arcturus Therape

ARCT

+6.17%

14.12

Gilead Sciences Inc

GILD

+0.30%

150.56

PRAH

Aptevo Therapeutics Inc

APVO

0.00%

1.840

Incyte Corp

INCY

-1.81%

125.31

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.